Patent ID: 7662921

Claim:
A method of treating a subject infected with a pathogenic virus, the method comprising administering alefacept (SEQ ID NO:4) to the subject, wherein the pathogenic virus is selected from the group consisting of hepatitis C (HCV), hepatitis B (HBV), hepatitis D (HDV), human T lymphotropic virus-1(HLTV-1), human T lymphotrophic virus-2 (HLTV-2), Epstein-Barr virus (EBV), cytomegalovirus (CMV), herpes simplex type 1 (HSV-1), herpes simplex type 2 (HSV-2), herpes zoster virus (HZV), herpes virus type 6 (HHV-6), herpes virus type 7 (HHV-7), and papillomavirus.